Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of morpho/immunological telehaematology file exchanges for the inclusion of patients with chronic lymphocytic leukaemia in a therapeutic trial.
Lesesve J, Palmiéri A, Brion A, Feugier P, Mahé B, Garand R; Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS). Lesesve J, et al. Int J Lab Hematol. 2008 Jun;30(3):256-8. doi: 10.1111/j.1751-553X.2007.00935.x. Int J Lab Hematol. 2008. PMID: 18479305 Clinical Trial. No abstract available.
The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique.
Nguyen-Khac F, Muller M, Chapiro E, Abermil N, Collonge-Rame MA, Daudignon A, Gaillard B, Guzun D, Ittel A, Lefebvre C, Lesesve JF, Mozziconacci MJ, Penther D, Quessada J, Settegrana C, Smagghe L, Terre C, Veronese L, Hirsch P, Troadec MB. Nguyen-Khac F, et al. Among authors: lesesve jf. Am J Hematol. 2024 Jul;99(7):1420-1422. doi: 10.1002/ajh.27328. Epub 2024 Apr 13. Am J Hematol. 2024. PMID: 38613825 No abstract available.
PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucémies.
Lenormand B, Béné MC, Lesesve JF, Bastard C, Tilly H, Lefranc MP, Faure GC, Garand R, Falkenrodt A, Kandel G, Solary E, Maynadié M, Callat MP, Thouret F, Monconduit M, Vannier JP. Lenormand B, et al. Among authors: lesesve jf. Leuk Lymphoma. 1998 Jan;28(3-4):329-42. doi: 10.3109/10428199809092688. Leuk Lymphoma. 1998. PMID: 9517504 Clinical Trial.
Prognostic relevance of soluble CD23 levels in CLL.
Lesesve JF, Florence AM, Maynadié GM, Feugier P. Lesesve JF, et al. Hematol J. 2001;2(5):355. doi: 10.1038/sj.thj.6200129. Hematol J. 2001. PMID: 11920272 No abstract available.
Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trial.
Brion A, Mahé B, Kolb B, Audhuy B, Colombat P, Maisonneuve H, Foussard C, Bureau A, Ferrand C, Lesesve JF, Béné MC, Feugier P; Groupe Ouest Est d’Etude des Leucémies et autres Maladies du Sang. Brion A, et al. Among authors: lesesve jf. Bone Marrow Transplant. 2012 Apr;47(4):542-8. doi: 10.1038/bmt.2011.117. Epub 2011 Jul 4. Bone Marrow Transplant. 2012. PMID: 21725374 Clinical Trial.
Interference of blast cell fragments with automated platelet counting.
Frotscher B, Salignac S, Muller M, Latger-Cannard V, Feugier P, Lesesve JF. Frotscher B, et al. Among authors: lesesve jf. Int J Lab Hematol. 2015 Oct;37(5):613-9. doi: 10.1111/ijlh.12371. Epub 2015 Apr 28. Int J Lab Hematol. 2015. PMID: 25923507
165 results